PATENT CLAIM ANALYSIS

Application Number: 15899061
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "210180"]

Abstract:
A compound of formula I, or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.

Claim (Index 2):
The compound as claimed in  claim 1 , wherein\n E 1  represents \u2014Cl and E 2  represents \u2014F, \u2014Cl, \u2014CH 3  or \u2014CF 3 , or E 1  represents \u2014CH 3  and E 2  represents \u2014F, \u2014Cl, \u2014CH 3 , \u2014CF 3  or \u2014CN.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14647400', '15447818', '15315461', '15315478', '11123755']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.801792029797159
- 35 USC 102 Novelty (BERT): 0.5908923085861871
- Combined Prediction Score: 0.7807020576760618
- Mean Citation Score: 440.228286
- Max Citation Score: 523.1518
- Similarity Product: 407.3106068429112

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test